Which stock is cheaper: SYNGENE or DIVISLAB?

Based on Price to Earnings, SYNGENE trades at a P/E of 66.3 while DIVISLAB trades at a P/E of 84.2.

Does SYNGENE or DIVISLAB have higher ROCE?

SYNGENE generates an ROCE of 7.3% compared to DIVISLAB's ROCE of 25.1%.

SYNGENE INTERNATIONAL LTD (SYNGENE) has a market cap of ₹15,402 Cr compared to DIVI S LABORATORIES LTD (DIVISLAB) with ₹2,47,470 Cr.

SYNGENEHealthcare

₹402.70+1.03%

Market Cap: ₹15,402 Cr

DIVISLABHealthcare

Leads (3/5)

₹9,780.00+1.20%

Market Cap: ₹2,47,470 Cr

Automated quantitative breakdown of fundamental strengths between SYNGENE and DIVISLAB.

Attractive ValuationSYNGENE (P/E 66.3)Trades at lower Price-to-Earnings

Capital EfficiencyDIVISLAB (ROCE 25.1%)Superior operating return on capital

Balance Sheet SafetyDIVISLABLower debt-to-equity ratio

Shareholder YieldSYNGENE (8.44%)Higher annual dividend yield

Green highlight indicates the stronger metric

Financial Metric	SYNGENE	DIVISLAB
Valuation Multiples
Market Capitalization	₹15,402 Cr	₹2,47,470 Cr
Price to Earnings (P/E)	66.30	84.21
Price to Book (P/B)	3.27	14.81
Profitability & Capital Efficiency
Return on Capital Employed (ROCE)	7.26%	25.07%
Return on Equity (ROE)	8.77%	13.84%
Operating Profit Margin (OPM)	9.37%	34.38%
Net Profit Margin (NPM)	7.97%	26.17%
Balance Sheet & Solvency
Debt to Equity Ratio	0.04	0.00
Dividend Yield	8.44%	0.33%
Historical Growth
3-Year Sales Growth (CAGR)	-3.41%	16.35%
Latest Quarter Financial Results
Quarterly Revenue (30 Jun 2026)	₹736 Cr	₹3,080 Cr
Quarterly Net Profit	₹-9 Cr	₹902 Cr